Analystreport

ADMA Biologics, Inc. (NASDAQ: ADMA) had its price target raised by analysts at Raymond James from $5.00 to $6.00.

ADMA Biologics Inc  (ADMA) 
Last adma biologics inc earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.admabiologics.com